Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery

NCT03353259 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03353259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03353259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Lead sponsor
Oslo University Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
November 28, 2017
Completion date
September 1, 2021
Enrollment
382 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma